ToxSci Advance Access published online on June 23, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfi235
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
* To whom correspondence should be addressed. In the field of gene expression analysis, DNA microarray technology has a major impact on many different areas including toxicogenomics, such as in predicting the adverse effects of new drug candidates and improving the process of risk assessment and safety evaluation. In this study, we investigated whether there is relationship between the hepatotoxic phenotypes and gene expression profiles of hepatotoxic chemicals measured by DNA microarray analyses. Sprague-Dawley rats (6 weeks old) were administered 5 hepatotoxicants: acetaminophen (APAP), bromobenzene, carbon tetrachloride, dimethylnitrosamine, and thioacetamide. Serum biochemical markers for liver toxicity were measured to estimate the maximal toxic time of each chemical. Hepatic mRNA was isolated and the gene expression profiles were analysed by DNA microarray containing 1,097 drug response genes, such as cytochrome P450s, other phase I and phase II enzymes, nuclear receptors, signal transducers, and transporters. All the chemicals tested generated specific gene expression patterns. APAP was sorted to a different cluster from the other 4 chemicals. From the gene expression profiles and maximal toxic time estimated by serum biochemical markers, we identified 10 up-regulated genes and 10 down-regulated genes as potential markers of hepatotoxicity. By Quality-Threshold (QT) clustering analysis, we identified major up- and down-regulated expression patterns in each group. Interestingly, the average gene expression patterns from the QT clustering were correlated with the mean value profiles from the biochemical markers. Furthermore, this correlation was observed at any extent of hepatotoxicity. In this study, we identified 17 potential toxicity markers and those expression profiles could estimate the maximal toxic time independently of the hepatotoxicity levels. This expression profile analysis could be one of the useful tools for evaluating a potential hepatotoxicant in the drug development process.
Received May 27, 2005
Accepted June 2, 2005
Risk Assessment
Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats
2 Life science group, Hitachi Ltd., Saitama, Japan
Tsuyoshi Yokoi, E-mail: TYOKOI{at}kenroku.kanazawa-u.ac.jp
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Dieterich, D. Iglehart, E. Riccio, J. C. Mirsalis, and H. H. Ng Microarray Evaluation of the Listeria monocytogenes Infection and Amoxicillin Treatment in Mice International Journal of Toxicology, May 1, 2008; 27(3): 265 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Fielden, A. Nie, M. McMillian, C. S. Elangbam, B. A. Trela, Y. Yang, R. T. Dunn II, Y. Dragan, R. Fransson-Stehen, M. Bogdanffy, et al. Interlaboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat Toxicol. Sci., May 1, 2008; 103(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zidek, J. Hellmann, P.-J. Kramer, and P. G. Hewitt Acute Hepatotoxicity: A Predictive Model Based on Focused Illumina Microarrays Toxicol. Sci., September 1, 2007; 99(1): 289 - 302. [Abstract] [Full Text] [PDF] |
||||

